Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The Centers for Disease Control and Prevention estimates that about 36,400 people contracted HIV in 2018.
A systematic review of hep C treatment outcomes in this population shows they have high cure rates and relatively low reinfection rates.
Federal judge rules in favor of nonprofit seeking to open the country’s first overdose prevention facility.
Opioid use disorder is fueling a rise in youth hepatitis C cases and a stabilization of a long decline in HIV among people who use drugs.
U.S. health care systems are seeking better solutions to the critical problem of drug diversion.
New cases of all three viruses have declined in the city over the past decade.
An analysis of newly diagnosed youths in California found they had limited access to opioid-related harm reduction services.
The drug can quickly reverse opioid-driven overdoses.
Judge’s ruling may pave the way for opening the nation’s first supervised overdose prevention facility.
National survey finds HBV rate is four times higher than that of the overall U.S. population.
The CDC estimates that 40 percent of the 1.1 million people with HIV are undiagnosed or not receiving medical care for the virus.
Researchers reviewed numerous studies to inform their detailed tips for better engaging people who inject opioid drugs in hepatitis C care.
Researchers modeled the differences between testing focused on baby boomers versus universal screening.
Baby boomers still make up the largest bloc of those with the virus, but youths’ injection drug use is sending their infection rates upward.
A speedy overview of the major scientific findings presented at the International AIDS Conference in Amsterdam (AIDS 2018)
Research suggests that individuals receiving opioid replacement therapy have a better chance of beating hep C through this method.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.